Last week @fda sends out clarification on who can and cannot compound #glp1 like #tirzeaptide and #semaglutide and this week ProRx 503b shuts down GLP 1 compounding while @martymakary is photographed holding bootleg # The FDA may be about to change everything for peptide research. Secretary RFK Jr. announced plans to move 14 peptides from Category 2 to Category 1. That means FDA recognized. Potentially prescribable through boomrx #peptides #fda #compoundingpharmacy #clinicalmedicine #patientaccess BoomRX The FDA didn't bring peptides back. It opened a formal docket. And that distinction matters. This is not a blanket approval. Not a wellness free for all. Not one announcement that changes everything overnight.